Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Leport, C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 114 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Le Moing, V; Chene, G; Carrieri, MP; Besnier, JM; Masquelier, B; Salamon, R; Bazin, C; Moatti, JP; Raffi, F; Leport, C
      Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Lewden, C; Raffi, F; Chene, G; Sobel, A; Leport, C
      Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy - Standardization to the general population

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Duval, X; Papastamopoulos, V; Longuet, P; Benoit, C; Perronne, C; Leport, C; Vilde, JL
      Definite Streptococcus bovis endocarditis: characteristics in 20 patients

      CLINICAL MICROBIOLOGY AND INFECTION
    4. Leport, C; Franck, J; Chene, G; Derouin, F; Ecobichon, JL; Pueyo, S; Miro, JM; Luft, BJ; Morlat, P; Dumon, H
      Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    5. Fidouh-Houhou, N; Duval, X; Bissuel, F; Bourbonneux, V; Flandre, P; Ecobichon, JL; Jordn, MC; Vilde, JL; Brun-Vezinet, F; Leport, C
      Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients

      CLINICAL INFECTIOUS DISEASES
    6. Longuet, P; Douard, MC; Arlet, G; Molina, JM; Benoit, C; Leport, C
      Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: The reservoir as a diagnostic and therapeutic tool

      CLINICAL INFECTIOUS DISEASES
    7. Duval, X; Trad, S; Le Moing, V; Longuet, P; Leport, C; Vilde, JL
      Paradoxical aggravation of tuberculosis after antiretroviral treatment in HIV-infected patients

      PRESSE MEDICALE
    8. Bail, P; Bizel, P; Bonnard, J; Compagnon, C; Dosquet, P; Dubois, S; Dupuis, G; Fabre, H; Glorion, B; Lienhart, A; Nicolas, F; Noel, AP; Pazart, L; Pinell, P; Pellerin, D; Sargos, P; Serin, D; Thouvenin, D; Thurin, JM; Chapiro, O; Cordonnier, D; Darcourt, G; Delcey, M; Esper, C; Freile, R; Grall, JC; Haxaire, C; Herrmann, P; Hirsch, E; Hirszowski, F; Jacquet, JP; Lascoumes, P; Lassner, E; Leport, C; Lieutaud, P; Locquet, C; Mairesse, JP; Mayaud, C; May-Levin, F; Michel, C; Mopin, J; Moser, S; Papa, M; Perrier, JM; Pochet, P; Richard, D; Sautron, JB; Torre, E; Tricoire, MJ; Vasseur, E; Wagner-Ballon, J
      Patient information: guidelines for physicians

      JOURNAL DES MALADIES VASCULAIRES
    9. Duval, X; Larger, E; Longuet, P; Leport, C; Vilde, JL
      Galactorrhoea, hyperprolactinaemia, and protease inhibitors

      LANCET
    10. Rabaud, C; Charreau, I; Izard, S; Raffi, F; Meiffredy, V; Leport, C; Guillemin, F; Yeni, P; Aboulker, JP
      Adverse reactions to cotrimoxazole in HIV-infected patients: Predictive factors and subsequent HIV disease progression

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    11. Descamps, V; Duval, X; Grossin, M; Crickx, B; Leport, C
      Topical cidofovir for bowenoid papulosis in an HIV-infected patient

      BRITISH JOURNAL OF DERMATOLOGY
    12. Le Moing, V; Eid, Z; Ecobichon, JL; Duval, X; Longuet, P; Elbim, C; Brun-Vezinet, F; Leport, C; Vilde, JL
      Long-term immunologic response in HIV-infected patients with CD4 cell counts <= 50/mm(3) when initiating protease inhibitor therapy.

      ANNALES DE MEDECINE INTERNE
    13. Duval, X; Djendli, S; Le Moing, V; Longuet, P; Barry, B; Leport, C; Vilde, JL
      Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease)

      AMERICAN JOURNAL OF MEDICINE
    14. Masur, H; Kaplan, JE; Holmes, KK; Alston, BL; Ampel, N; Anderson, JR; Baker, AC; Barr, D; Bartlett, JG; Bennett, JE; Benson, CA; Bozzette, SA; Chaisson, RE; Crumpacker, CS; Currier, JS; Deyton, L; Drew, WL; Duncan, WR; Eisinger, RW; El-Sadr, W; Feinberg, J; Freedberg, KA; Furrer, H; Gnann, JW; Goldberger, MJ; Goldie, S; Goosby, EP; Gross, PA; Hafner, R; Havlir, D; Hooton, TM; Jabs, DA; Jacobson, MA; Janoff, E; Kitahata, M; Kovacs, JV; Leport, C; Levin, MJ; Lopez, JC; Marco, M; Mayers, DL; Melnick, DA; Mofenson, LM; Montaner, JSG; Moore, R; Neaton, J; Nelson, C; O'Neill, JF; Palefsky, J; Pau, A; Phair, JP; Piscitelli, S; Polis, MA; Quinn, TC; Reiss, P; Rimland, D; Sears, CL; Seeff, L; Sepkowitz, KA; Slama, TG; Sloand, EM; Spector, SA; Thomas, DL; Van Dyke, RB; Watts, DH; Wheat, LJ; Whitcup, SM; Williams, P; Wright, TC; Castro, KG; DeCock, KM; Dowell, SF; Dworkin, MS; Dykewicz, C; Ellerbrock, T; Hajjeh, R; Holmberg, S; Holtgrave, DR; Jaffe, HW; Jones, JL; Juranek, DD; Mast, E; Navin, T; Pellett, PE; Reeves, WC; Stewart, JA; Villarino, ME
      1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

      CLINICAL INFECTIOUS DISEASES
    15. Vincent, I; D'Herouville, D; Moulin, P; Bugler, C; Fraval, J; Mallet, D; Salamagne, MH; Vilde, JL; Jodelet, D; Leport, C
      Modalities of palliative care in hospitalized patients with advanced AIDS

      AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
    16. Salmon-Ceron, D; Mazeron, MC; Chaput, S; Boukli, N; Senechal, R; Houhou, N; Katlama, C; Matheron, S; Fillet, AM; Gozlan, J; Leport, C; Jeantils, V; Freymuth, F; Costagliola, D
      Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

      AIDS
    17. Anduze-Faris, BM; Fillet, AM; Gozlan, J; Lancar, R; Boukli, N; Gasnault, J; Caumes, E; Livartowsky, J; Matheron, S; Leport, C; Salmon, D; Costagliola, D; Katlama, C
      Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients

      AIDS
    18. Derouin, F; Jacqz-Aigrain, E; Thulliez, P; Couvreur, J; Leport, C
      Cotrimoxazole for prenatal treatment of congenital toxoplasmosis?

      PARASITOLOGY TODAY
    19. Duval, X; Le Moing, V; Longuet, P; Leport, C; Vilde, JL; Lamotte, C; Peytavin, G; Farinotti, R
      Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    20. Saves, M; Raffi, F; Clevenbergh, P; Marchou, B; Waldner-Combernoux, A; Morlat, P; Le Moing, V; Riviere, C; Chene, G; Leport, C
      Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    21. Benveniste, O; Dereuddre-Bosquet, N; Clayette, P; Leport, C; Vilde, JL; Dormont, D
      High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    22. Grabar, S; Le Moing, V; Goujard, C; Leport, C; Kazatchkine, MD; Costagliola, D; Weiss, L
      Clinical outcome of patients with HIV-1 infection according to immunologicand virologic response after 6 months of highly active antiretroviral therapy

      ANNALS OF INTERNAL MEDICINE
    23. Hermieu, JF; Leport, C; Ravery, V; Delmas, V; Boccon-Gibod, L
      Lipodystrophy: a complication of protease inhibitors in HIV seropositive patients.

      PROGRES EN UROLOGIE
    24. Le Moing, V; Lacassin, F; Delahousse, M; Duval, X; Longuet, P; Leport, C; Vilde, JL
      Use of corticosteroids in glomerulonephritis related to infective endocarditis: Three cases and review

      CLINICAL INFECTIOUS DISEASES
    25. Benveniste, O; Longuet, P; Duval, X; Le Moing, V; Leport, C; Vilde, JL
      Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir

      CLINICAL INFECTIOUS DISEASES
    26. Salmon-Ceron, D; Fillet, AM; Aboulker, JP; Gerard, L; Houhou, N; Carriere, I; Ostinelli, J; Vilde, JL; Brun-Vezinet, F; Leport, C
      Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia

      CLINICAL INFECTIOUS DISEASES
    27. Longuet, P; Duval, X; Le Moing, V; Scanvic-Hameg, A; Leport, C; Vilde, JL
      Antibiotic prophylaxis in patients at risk of a nosocomial outbreak of legionnellosis

      PRESSE MEDICALE
    28. Raffi, F; Franck, J; Pelloux, H; Derouin, F; Reliquet, V; Ambroise-Thomas, P; Aboulker, JP; Leport, C; Dumon, H
      Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    29. Taille, C; Fournier, PE; Bissuel, F; Longuet, P; Leport, C; Vilde, JL
      Meningoencephalitis during Q fever.

      MEDECINE ET MALADIES INFECTIEUSES
    30. Le Moing, V; Geniteau, M; Lacassin, F; Nicaise, P; Leport, C; Labarre, C; Vilde, JL
      Imbalance of immunoglobulin G subclasses in HIV-infected patients with pneumococcal infection.

      MEDECINE ET MALADIES INFECTIEUSES
    31. Duval, X; Peytavin, G; Fouqueray, B; Leport, C; Vilde, JL
      Renin-angiotensin system inhibition in a patient having an overdose of HIVprotease inhibitor

      AIDS
    32. Francois, B; Duval, X; Le Moing, V; Bruneel, F; Leport, C; Vilde, JL
      Bupivacain-induced meningitis

      REVUE DE MEDECINE INTERNE
    33. Assayag, P; Thuaire, C; Benamer, H; Sebbah, J; Leport, C; Brochet, E
      Partial rupture of the tricuspid valve after extraction of permanent pacemaker leads: Detection by transesophageal echocardiography

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    34. Masur, H; Kaplan, JE; Holmes, KK; Alston, BL; Ampel, N; Anderson, JR; Baker, AC; Barr, D; Bartlett, JG; Bennett, JE; Benson, CA; Bozzette, SA; Chaisson, RE; Crumpacker, CS; Currier, JS; Deyton, L; Drew, WL; Duncan, WR; Eisinger, RW; El-Sadr, W; Feinberg, J; Freedberg, KA; Furrer, H; Gnann, JW; Goldberger, MJ; Goldie, S; Goosby, EP; Gross, PA; Hafner, R; Havlir, D; Hooton, TM; Jabs, DA; Jacobson, MA; Janoff, E; Kitahata, M; Kovacs, JV; Leport, C; Levin, MJ; Lopez, JC; Marco, M; Mayers, DL; Melnick, DA; Mofenson, LM; Montaner, JSG; Moore, R; Neaton, J; Nelson, C; O'Neill, JF; Palefsky, J; Pau, A; Phair, JP; Piscitelli, S; Polis, MA; Quinn, TC; Reiss, P; Rimland, D; Sears, CL; Seeff, L; Sepkowitz, KA; Slama, TG; Sloand, EM; Spector, SA; Thomas, DL; Van Dyke, RB; Watts, DH; Wheat, LJ; Whitcup, SM; Williams, P; Wright, TC; Castro, KG; DeCock, KM; Dowell, SF; Dworkin, MS; Dykewicz, C; Ellerbrock, T; Hajjeh, R; Holmberg, S; Holtgrave, DR; Jaffe, HW; Jones, JL; Juranek, DD; Mast, E; Navin, T; Pellett, PE; Reeves, WC; Stewart, JA; Villarino, ME; Kaplan, JE
      1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

      ANNALS OF INTERNAL MEDICINE
    35. DEROUIN F; GERARD L; FARINOTTI R; MASLO C; LEPORT C
      DETERMINATION OF THE INHIBITORY EFFECT ON TOXOPLASMA GROWTH IN THE SERUM OF AIDS PATIENTS DURING ACUTE THERAPY FOR TOXOPLASMIC ENCEPHALITIS

      Journal of acquired immune deficiency syndromes and human retrovirology
    36. Leport, C; Descamps, D; Lacassin, F; Collin, G; Tilly, F; Vilde, JL; Brun-Vezinet, F
      Assessment of codon 215 mutation in 10 patients with slow progression of HIV infection, on long-term zidovudine monotherapy

      MEDECINE ET MALADIES INFECTIEUSES
    37. Leport, C; Perronne, C; Vilde, JL
      Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children)

      MEDECINE ET MALADIES INFECTIEUSES
    38. LEMOING V; BISSUEL F; COSTAGLIOLA D; EID Z; CHAPUIS F; MOLINA JM; SALMONCERON D; BRASSEUR P; LEPORT C
      DECREASED PREVALENCE OF INTESTINAL CRYPTOSPORIDIOSIS IN HIV-INFECTED PATIENTS CONCOMITANT TO THE WIDESPREAD USE OF PROTEASE INHIBITORS

      AIDS
    39. CHENE G; MORLAT P; LEPORT C; HAFNER R; DEQUAE L; CHARREAU I; ABOULKER JP; LUFT B; AUBERTIN J; VILDE JL; SALAMON R
      INTENTION-TO-TREAT VS. ON-TREATMENT ANALYSES OF CLINICAL-TRIAL DATA -EXPERIENCE FROM A STUDY OF PYRIMETHAMINE IN THE PRIMARY PROPHYLAXIS OF TOXOPLASMOSIS IN HIV-INFECTED PATIENTS

      Controlled clinical trials
    40. MAINARDI JL; LACASSIN F; GUILLOY Y; GOLDSTEIN FW; LEPORT C; ACAR JF; VILDE JL
      LOW-RATE OF CLOSTRIDIUM-DIFFICILE COLONIZATION IN AMBULATORY AND HOSPITALIZED HIV-INFECTED PATIENTS IN A HOSPITAL UNIT - A PROSPECTIVE SURVEY

      The Journal of infection
    41. Benveniste, O; Bruneel, F; Bedos, JP; Wolff, M; Leseche, G; Leport, C; Vilde, JL; Vachon, F; Regnier, B
      Ruptured mycotic pulmonary artery aneurysm: an unusual complication of right-sided endocarditis

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    42. RABAUD C; MAY T; BEUSCART C; REYNES J; LEPORT C; CANTON P
      CEREBRAL TOXOPLASMOSIS IN HIV-INFECTED PA TIENTS PRESENTING WITH SULFAMETHOXAZOLE-TRIMETHOPRIM INTOLERANCE

      Annales de medecine interne
    43. PUEYO S; SALMI LR; CHENE G; LEPORT C; MORLAT P; DEQUAE L; GREGOIRE V; HAFNER R; VILDE JL; LUFT BJ; AUBERTIN J; SALAMON R
      SURVIVAL AFTER AIDS-DEFINING EVENTS IN PATIENTS WITH LESS-THAN-200 LYMPHOCYTES CD4+X10(6) L WHO ARE TOXOPLASMOSIS ANTIBODY-POSITIVE/

      Journal of acquired immune deficiency syndromes and human retrovirology
    44. GERARD L; LEPORT C; FLANDRE P; HOUHOU B; SALMONCERON D; PEPIN JM; MANDET C; BRUNVEZINET F; VILDE JL
      CYTOMEGALOVIRUS (CMV) VIREMIA AND THE CD4(-IMMUNODEFICIENCY-VIRUS() LYMPHOCYTE COUNT AS PREDICTORS OF CMV DISEASE IN PATIENTS INFECTED WITHHUMAN)

      Clinical infectious diseases
    45. ROUSSEAU F; PUEYO S; MORLAT P; HAFNER R; CHENE G; LEPORT C; LUFT BJ; MIRO J; AUBERTIN J; SALAMON R; VILDE JL
      INCREASED RISK OF TOXOPLASMIC ENCEPHALITIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH PYRIMETHAMINE-RELATED RASH

      Clinical infectious diseases
    46. RAGUIN G; LERUEZVILLE M; GREGOIRE V; DEPLANCHE M; LEPORT C; MORINET F; VILDE JL
      LOW-PREVALENCE OF ACTIVE PARVOVIRUS B19 INFECTION IN HIV-INFECTED PATIENTS

      European journal of clinical microbiology & infectious diseases
    47. BESNIER JM; LEPORT C
      CLINICAL IMPLICATIONS OF ANTIBIOTIC-RESIS TANCE OF ENTEROCOCCI

      La Presse medicale
    48. DEVINCENZI I; JADAND C; COUTURIER E; BRUNET JB; GALLAIS H; GASTAUT JA; GOUJARD C; DEVEAU C; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; DELLAMONICA P; PERBOST I; CARLES M; MONDAIN V; GUILLEVIN L; JAROUSSE B; TROGOFF B; LEBRAS P; QUERTAINMONT Y; VILDE JL; LEPORT C; COLASSANTE U; KAZATCHKINE M; VELLAY A; BUISSON M; CASSUTO JP; REBOULOT B; SERENI D; GOMEZ V; BACHMEYER C; MARS ME; GALLAIS J; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; KATLAMA C; BRUCKER G; DHIVER C; DROGOUL MP
      PREGNANCY AND CONTRACEPTION IN A FRENCH COHORT OF HIV-INFECTED WOMEN

      AIDS
    49. RAFFI F; ABOULKER JP; MICHELET C; RELIQUET V; PELLOUX H; HUART A; POIZOTMARTIN I; MORLAT P; DUPAS B; MUSSINI JM; LEPORT C; ALLEGRE T; AUBERTIN J; BEYLOT J; CANTON P; AMBROISETHOMAS P; MICOUD M; PEYRAMOND D; TREPO C; GASTAUT JA; JANBON F; BARRIER JH; LITOUX P; DELLAMONICA P; CARBON C; COULAUD JP; VACHON F; VILDE JL; SICARD D; COMPAGNUCCI A; MARSAL L; MODAI J; SELIGMANN M; LANG JM; LAFEUILLADE A
      A PROSPECTIVE-STUDY OF CRITERIA FOR THE DIAGNOSIS OF TOXOPLASMIC ENCEPHALITIS IN 186 AIDS PATIENTS

      AIDS
    50. LACASSIN F; LOUSSERTAJAKA I; LEPORT C; BRUNVEZINET F; VILDE JL; SIMON F
      RAPID FATAL EVOLUTION IN 2 CASES OF INFECTION DUE TO HIV-1 UNCOMMON SUBTYPES IN FRANCE

      AIDS
    51. MOLINA JM; GOGUEL J; SARFATI C; CHASTANG C; DESPORTESLIVAGE I; MICHIELS JF; MASLO C; KATLAMA C; COTTE L; LEPORT C; RAFFI F; DEROUIN F; MODAI J
      POTENTIAL EFFICACY OF FUMAGILLIN IN INTESTINAL MICROSPORIDIOSIS DUE TO ENTEROCYTOZOON-BIENEUSI IN PATIENTS WITH HIV-INFECTION - RESULTS OF A DRUG SCREENING STUDY

      AIDS
    52. GOGUEL J; KATLAMA C; SARFATI C; MASLO C; LEPORT C; MOLINA JM
      REMISSION OF AIDS-ASSOCIATED INTESTINAL MICROSPORIDIOSIS WITH HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY

      AIDS
    53. MEYER L; MAGIEROWSKA M; HUBERT JB; ROUZIOUX C; DEVEAU C; SANSON F; DEBRE P; DELFRAISSY JF; THEODOROU I; BARY M; BURGARD M; DORMONT J; BOUE F; LEVY A; DELLAMONICA P; PERBOST I; CARLES M; MONDAIN V; GUILLEVIN L; JAROUSSE B; TROGOFF B; LEBRAS P; GOUJARD C; QUERTAINMONT Y; VILDE JL; LEPORT C; COLASSANTE U; KAZATCHKINE M; VELLAY A; BUISSON M; CASSUTO JP; REBOULOT B; QUARANTA M; SERENI D; GOMEZ V; BACHMEYER C; GALLAIS H; MARS ME; GALLAIS J; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; KATLAMA C; BRUCKER G; GASTAUT JA; DHIVER C; DROGOUL MP
      EARLY PROTECTIVE EFFECT OF CCR-5 DELTA-32 HETEROZYGOSITY ON HIV-1 DISEASE PROGRESSION - RELATIONSHIP WITH VIRAL LOAD

      AIDS
    54. BARETE S; BISSUEL F; LONGUET P; POCIDALO MA; LEPORT C; VILDE JL
      AGRANULOCYTOSIS IN A PATIENT ON TERBINAFI NE THERAPY

      La Revue de medecine interne
    55. CARRE N; ROBAIN M; DUSSAIX E; SALMONCERON D; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; LEVY A; BOUE F; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLC C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; DELFRAISSY JF; LEBRAS P; GOUJARD C; QUERTAINMONT Y; GUILLEVIN L; JAROUSSE B; TROGOFF B
      SEXUAL FACTORS ASSOCIATED WITH CYTOMEGALOVIRUS SEROPOSITIVITY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN

      Sexually transmitted diseases
    56. MORLAT P; LEPORT C
      PROPHYLAXIS FOR TOXOPLASMOSIS IN IMMUNOSU PPRESSED PATIENTS

      Annales de medecine interne
    57. EDELMAN L; DEVEAU C; RAPHAEL M; MONCHATRE E; GABARRE J; DEVILLECHABROL A; PIALOUX G; EMILIE D; JOAB I; GALANAUD P; ROUZIOUX C; BARY M; BURGARD M; GALLAIS H; MARS ME; GALLAIS J; DELLAMONICA P; PERBOST I; CARLES M; CASSUTO JP; REBOULOT B; QUARANTA M; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; VITTECOQ D; BOLLIOT C; PECHALAT MT; LEBRAS P; GOUJARD C; QUERTAINMONT Y; GASTAUT JA; DHIVER C; DROGOUL MP; GAZENGEL C; PERTUISSET N; ROTSCHILD M; HERSON S; COUTELLIER A; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; PEYNET J; LAUX C; KATLAMA C; BRUCKER G; LAURIAN Y; KEBEDJI L; LAMBERT T; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; SULTAN Y; GAUTREAU C; PICARD F; GUILLEVIN L; LAROUSSE B; TROGOFF B
      SERUM INTERLEUKIN-10 IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME LYMPHOMA PATIENTS

      European cytokine network
    58. FLANDRE P; BOUFASSA F; GERARD L; CARRE N; PERSOZ A; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLD C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; LEBRAS P; GOUJARD C; QUERTAINMONT Y; ANDRIEU JM; EVEN P; GUILLEVIN L; JAROUSSE B; TROGOFF B
      THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO)

      Journal of acquired immune deficiency syndromes and human retrovirology
    59. RABAUD C; MAY T; LUCET JC; LEPORT C; AMBROISETHOMAS P; CANTON P
      PULMONARY TOXOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A FRENCH NATIONAL SURVEY

      Clinical infectious diseases
    60. GERARD L; FLANDRE P; RAGUIN G; LEGALL JR; VILDE JL; LEPORT C
      LIFE EXPECTANCY IN HOSPITALIZED-PATIENTS WITH AIDS - PROGNOSTIC FACTORS ON ADMISSION

      Journal of palliative care
    61. DELAHAYE F; LEPORT C
      PROPHYLAXIS OF INFECTIVE ENDOCARDITIS

      La Presse medicale
    62. LEPORT C; AMBROISETHOMAS P; BAZIN C; CHENE G; DEROUIN F; KATLAMA C; MAYAUD C; PELLOUX H; RAFFI F; VILDE JL
      RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DEFINITION OF INDICATIONS FOR PRIMARY PROPHYLAXIS - PRPOSALS OF THE PE-TOXOPLASMOSE-ET-AUTRES-INFECTIONS-A-PROTOZOAIRE

      La Presse medicale
    63. DEROUIN F; LEPORT C; PUEYO S; MORLAT P; ECOBICHON JL; LETRILLART B; CHENE G; LUFT B; AUBERTIN J; HAFNER R; VILDE JL; SALAMON R
      PREDICTIVE VALUE OF TOXOPLASMA-GONDII ANTIBODY-TITERS ON THE OCCURRENCE OF TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS

      AIDS
    64. CARRE N; MEYER L; BOUFASSA F; DEVEAU C; PERSOZ A; ROUZIOUX C; VILDE JL; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; BECLERE A; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLC C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; LEBRAS P; GOUJARD C; QUERTAINMONT Y; ANDRIEU JM; EVEN P; GUILLEVIN L; JAROUSSE J; TROGOFF B
      HIGH-RISK OF HIV DISEASE PROGRESSION AFTER INFECTION THROUGH A SEXUALPARTNER WITH AIDS

      AIDS
    65. BISSUEL F; HOUHOU N; LEPORT C; BRUNVEZINET F; VILDE JL
      HEPATITIS-E ANTIBODIES AND HIV STATUS

      Lancet
    66. LACASSIN F; DAMOND F; CHOCHILLON C; LONGUET P; LEBRAS J; VILDE JL; LEPORT C
      RESPONSE TO FLUCONAZOLE BY 23 PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND ORAL CANDIDIASIS - PHARMACOLOGICAL AND MYCOLOGICAL FACTORS

      Antimicrobial agents and chemotherapy
    67. LEPORT C; CHENE G; MORLAT P; LUFT BJ; ROUSSEAU F; PUEYO S; HAFNER R; MIRO J; AUBERTIN J; SALAMON R; VILDE JL; BLANC AP; SCHMITT JL; ARLAUD J; ESTAVOYER JM; GUILLEVIN L; BENTATA M; BEYLOT J; LACUT JY; GRANIER P; COSNARD F; BAZIN C; DORMONT J; REY M; DELAUNAY C; TROISVALLET D; MICOUD M; WEINBRECK P; TREPO C; GALLAIS H; GASTAUT JA; ALLARD C; JANBON F; CANTON P; GROLLEAU JY; CASSUTO J; DELLAMONICA P; DURET P; FROTTIER J; HERSON S; SELIGMANN M; SERENI D; GIRAUDON BB; DIEN G; RUEL M; STORCK D; JAUBERT D; LAFEUILLADE A; MOUTON Y; CHOUTET P; LAFAIX C; GATELL JM; GUELAR A; MILDVAN D; SOIERO R; JACOBSON JM; MURRAY HW; STEIGBIGEL NH; SACHS HH; VALENTINE F; GRIECO MH; ARMSTRONG D; LEDERMAN M; BARTLETT JA; WASKIN HA; NICHOLAS P; FESSEL JW; MACARTHUR RD; GLATT AE; PHAIR JP; POWDERLY W; HEWITT R; STEIGBIGEL RT; BLAIR DC; SKAHAN KJ; FRAME P; CHEESEMAN SH; CONNOR EM; BALFOUR HH; VANDERHORST C; HO M
      PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL

      The Journal of infectious diseases
    68. LEPORT C; AMBROISETHOMAS P; BAZIN C; CHENE G; DEROUIN F; KATLAMA C; MAYAUD C; PELLOUX H; RAFFI F; VILDE JL
      RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N HIV-INFECTED PATIENTS - DEFINING INDICATIONS FOR PRIMARY PROPHYLAXIS

      Annales de medecine interne
    69. SELTONSUTY C; HOEN B; DELAHAYE F; LACASSIN F; GOULET V; ETIENNE J; BRIANCON S; LEPORT C
      COMPARISON OF INFECTIVE ENDOCARDITIS IN PATIENTS WITH AND WITHOUT PREVIOUSLY RECOGNIZED HEART-DISEASE

      The American journal of cardiology
    70. HOEN B; SELTONSUTY C; LACASSIN F; ETIENNE J; BRIANCON S; LEPORT C; CANTON P
      INFECTIVE ENDOCARDITIS IN PATIENTS WITH NEGATIVE BLOOD CULTURES - ANALYSIS OF 88 CASES FROM A ONE-YEAR NATIONWIDE SURVEY IN FRANCE

      Clinical infectious diseases
    71. DUVAL X; PATY MC; LONGUET P; LACASSIN F; PERRONNE C; LEPORT C; VILDE JL
      ACUTE PNEUMOCOCCAL PNEUMONIAE IN HIV-INFE CTED PATIENTS - CLINICAL-FEATURES AND EVOLUTION IN 27 PATIENTS

      La Presse medicale
    72. LACASSIN F; LEPORT C
      OROPHARYNGEAL AND INTESTINAL CANDIDIASIS LN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Medecine et maladies infectieuses
    73. LEPORT C
      ANTIFUNGAL AZOLE PREPARATIONS - USE IN CL INICAL MEDICINE

      Medecine et maladies infectieuses
    74. LEPORT C; LACASSIN F
      METACILLIN-RESISTANT STAPHYLOCCIC ENDOCAR DITIS

      Medecine et maladies infectieuses
    75. LACASSIN F; LEPORT C
      OROPHARYNGEAL AND INTESTINAL CANDIDIASIS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Medecine et maladies infectieuses
    76. LEPORT C
      ANTIFUNGAL AZOLE PREPARATIONS - USE IN CL INICAL MEDICINE

      Medecine et maladies infectieuses
    77. LUCASSIN F; MINO JC; BENOIT C; PERRONNE C; LEPORT C; VILDE JL
      ONE CASE OF FOWL SALMONELLOSIS

      La Revue de medecine interne
    78. DELAHAYE F; GOULET V; LACASSIN F; ECOCHARD R; SELTONSUTY C; HOEN B; ETIENNE J; BRIANCON S; LEPORT C
      CHARACTERISTICS OF INFECTIVE ENDOCARDITIS IN FRANCE IN 1991 - A 1-YEAR SURVEY

      European heart journal
    79. LACASSIN F; HOEN B; LEPORT C; SELTONSUTY C; DELAHAYE F; GOULET V; ETIENNE J; BRIANCON S
      PROCEDURES ASSOCIATED WITH INFECTIVE ENDOCARDITIS IN ADULTS - A CASE-CONTROL STUDY

      European heart journal
    80. LEPORT C; HORSTKOTTE D; BURCKHARDT D; HALEES A; DANIEL WG; DURACK D; FRANCIOLI P; GUTSCHIK E; BLACKETT KN; SIMMONS NA; STAMBOULIAN D; VANDERMEER JTM; WILSON W
      ANTIBIOTIC-PROPHYLAXIS FOR INFECTIVE ENDOCARDITIS FROM AN INTERNATIONAL GROUP OF EXPERTS TOWARDS A EUROPEAN CONSENSUS

      European heart journal
    81. LHERITEAU F; ENTENZA JM; LACASSIN F; LEPORT C; GLAUSER MP; MOREILLON P
      RP-59500 PROPHYLAXIS OF EXPERIMENTAL ENDOCARDITIS DUE TO ERYTHROMYCIN-SUSCEPTIBLE AND ERYTHROMYCIN-RESISTANT ISOGENIC PAIRS OF VIRIDANS GROUP STREPTOCOCCI

      Antimicrobial agents and chemotherapy
    82. LACASSIN F; SCHAFFO D; PERRONNE C; LONGUET P; LEPORT C; VILDE JL
      CLARITHROMYCIN-MINOCYCLINE COMBINATION AS SALVAGE THERAPY FOR TOXOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Antimicrobial agents and chemotherapy
    83. LONGUET P; LORTHOLARY O; BENOIT C; LEPORT C; VILDE JL
      ESCHERICHIA-COLI BACTEREMIA AND CELLULITI S IN AIDS - 2 CASE-REPORTS

      Annales de medecine interne
    84. LORTHOLARY O; LISOVOSKI F; BRECHOT JM; LONGUET P; PERRONNE C; LEPORT C; VILDE JL
      MYELITIS DUE TO TOXOPLASMA-GONDII IN A PATIENT WITH AIDS

      Clinical infectious diseases
    85. PERRONNE C; SABA J; BEHLOUL Z; SALMONCERON D; LEPORT C; VILDE JL; KAHN MF
      PYOGENIC AND TUBERCULOUS SPONDYLODISKITIS (VERTEBRAL OSTEOMYELITIS) IN 80 ADULT PATIENTS

      Clinical infectious diseases
    86. ANGLARET X; SABA J; PERRONNE C; LACASSIN F; LONGUET P; LEPORT C; VILDE JL
      EMPIRIC ANTITUBERCULOSIS TREATMENT - BENEFITS FOR EARLIER DIAGNOSIS AND TREATMENT OF TUBERCULOSIS

      Tubercle and lung disease
    87. BISSUEL F; LEPORT C; PERRONNE C; LONGUET P; VILDE JL
      FEVER OF UNKNOWN ORIGIN IN HIV-INFECTED PATIENTS - A CRITICAL ANALYSIS OF A RETROSPECTIVE SERIES OF 57 CASES

      Journal of internal medicine
    88. DALEINE G; DENIAU M; MATHERON S; LEPORT C; LEBRAS J
      VISCERAL LEISHMANIASIS DURING HIV-INFECTI ON - ADVANTAGES OF ELISA SERODIAGNOSIS

      La Presse medicale
    89. LEPORT C; AMBROISETHOMAS P; CHENE G; DEROUIN F; KATLAMA C; RAFFI F; VILDE JL
      UPDATE ON CONSENSUAL PROPOSITIONS - COTRI MOXAZOLE AS PRIMARY PROPHYLAXIS FOR TOXOPLASMOSIS IN HIV-INFECTED PATIENTS - UP-ON-TOXOPLASMOSIS-AND-OTHER-PROTOZOAL-INFECTIONS - COORDINATING ACTION N5-ANRS

      Medecine et maladies infectieuses
    90. BESNIER JM; GUEROUT T; MION P; CHOUTET P; LEPORT C
      CURRENT ASPECTS OF ENTEROCOCCAL ENDOCARDI TIS

      Medecine et maladies infectieuses
    91. MENTEC H; LEPORT C; LEPORT J; MARCHE C; HARZIC M; VILDE JL
      CYTOMEGALOVIRUS COLITIS IN HIV-1-INFECTED PATIENTS - A PROSPECTIVE RESEARCH IN 55 PATIENTS

      AIDS
    92. LEPORT C; LACASSIN F
      BACTERIAL-ENDOCARDITIS - DIAGNOSTIC CIRCUMSTANCES - RESPONSE

      La Revue de medecine interne
    93. RABAUD C; MAY T; AMIEL C; KATLAMA C; LEPORT C; AMBROISETHOMAS P; CANTON P
      EXTRACEREBRAL TOXOPLASMOSIS IN PATIENTS INFECTED WITH HIV - A FRENCH NATIONAL SURVEY

      Medicine
    94. WALCKENAER G; LEPORT C; LONGUET P; PERRONNE C; LACASSIN F; VILDE JL
      RELAPSE OF BRAIN TOXOPLASMOSIS IN 15 AIDS PATIENTS

      Annales de medecine interne
    95. LORTHOLARY O; ROZENBERG F; PERRONNE C; DJEBBOUR S; LEPORT C; VILDE JL
      HERPES-SIMPLEX VIRUS TYPE-2 DNA IN CEREBROSPINAL-FLUID OF A WOMAN WITH RECURRENT MENINGITIS

      Clinical infectious diseases
    96. ROUSSEAU F; PERRONNE C; RAGUIN G; THOUVENOT D; VIDAL A; LEPORT C; VILDE JL
      NECROTIZING RETINITIS AND CEREBRAL VASCULITIS DUE TO VARICELLA-ZOSTERVIRUS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    97. CAMUS C; LEPORT C; RAFFI F; MICHELET C; CARTIER F; VILDE JL
      SUSTAINED BACTEREMIA IN 26 PATIENTS WITH A PERMANENT ENDOCARDIAL PACEMAKER - ASSESSMENT OF WIRE REMOVAL

      Clinical infectious diseases
    98. LORTHOLARY O; PERRONNE C; LEPORT J; LEPORT C; VILDE JL
      PRIMARY CYTOMEGALOVIRUS-INFECTION ASSOCIATED WITH THE ONSET OF ULCERATIVE-COLITIS

      European journal of clinical microbiology & infectious diseases
    99. ROUSSEAU F; PERRONNE C; DENY P; MESTASSI R; LARAKI H; MARCHE C; LEPORT C; VILDE JL
      PROLONGED AND FATAL DISSEMINATED CYTOMEGALOVIRUS-INFECTION IN AN IMMUNOCOMPETENT WOMAN

      European journal of clinical microbiology & infectious diseases
    100. SABA J; MORLAT P; RAFFI F; HAZEBROUCQ V; JOLY V; LEPORT C; VILDE JL
      PYRIMETHAMINE PLUS AZITHROMYCIN FOR TREATMENT OF ACUTE TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS

      European journal of clinical microbiology & infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 22:59:01